Vascular lesions of the head and neck: an update on classification and imaging review

Brahmbhatt, Akshaar; Skalski, Kamila; Bhatt, Alok A.

doi:10.1186/s13244-019-0818-3

Cited by 65 publications

(74 citation statements)

References 73 publications

(79 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The diagnosis of OVAs was established based on clinical criteria and on the history of the anomaly according to Mulliken and Glowacki ( 13 ) using the latest classification for vascular anomalies approved by the International Society for the Study of Vascular Anomalies workshop ( 14 ). Functional or esthetic criteria were used for treatment indication.…”

Section: Methodsmentioning

confidence: 99%

What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?

Kato¹,

Ribeiro²,

Abreu³

et al. 2020

Med Oral

View full text Add to dashboard Cite

Background This study compared three different concentrations of EO (1.25%, 2.5% and 5%) for the treatment of oral vascular anomalies (OVAs). Material and Methods This was a retrospective comparative analysis of patients with OVAs treated with EO. Anomalies smaller than 20 mm were included. The patients were treated with 1.25% (G1), 2.5% (G2), and 5% (G3) and clinical data were obtained. The number of sessions, the final volume and dose of EO were statistically analyzed to verify effectiveness and safety of the treatment. The different concentrations of EO were compared considering the number of sessions, the final volume and total dose of EO. Analysis of covariance (ANCOVA) was used to evaluate the influence of covariates on the outcomes. A p -value < 0.05 was considered significant. Results Nineteen women and 11 men with a median age of 54 years were included. The OVAs were most frequent in the lip (n=14) and cheek (n=9). All lesions exhibited complete clinical healing within 28 days. Patients of G3 required fewer sessions than those of G2 ( p =0.017), a lower final volume compared to the other groups ( p <0.001), and a lower total dose than G1 ( p <0.001). Patients of G1 used a lower total dose than G2 ( p =0.003). Conclusions The concentration of 5% EO performed better than 1.25% and 2.5% for sclerotherapy of OVAs measuring up to 20 mm. This preliminary result should be the preferred concentration of EO to provide an effective and safe treatment of OVAs. Key words: Ethanolamine oleate, sclerotherapy, vascular malformations, hemangioma, oral mucosa.

show abstract

Section: Methodsmentioning

confidence: 99%

What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?

Kato¹,

Ribeiro²,

Abreu³

et al. 2020

Med Oral

View full text Add to dashboard Cite

show abstract

“…The ISSVA as well as the WHO classification of soft tissue tumours distinguishes between benign vascular tumours, locally aggressive or low metastatic risk intermediate malignant vascular tumours, and malignant vascular tumours [ 55 , 57 , 65 ]. Some of these tumours preferentially affect the hand (Table 5 ).…”

Section: Different Disease Entitiesmentioning

confidence: 99%

CT angiography and MRI of hand vascular lesions: technical considerations and spectrum of imaging findings

Blum¹,

Gillet²,

Athlani

et al. 2021

Insights Imaging

View full text Add to dashboard Cite

Vascular lesions of the hand are common and are distinct from vascular lesions elsewhere because of the terminal vascular network in this region, the frequent hand exposure to trauma and microtrauma, and the superficial location of the lesions. Vascular lesions in the hand may be secondary to local pathology, a proximal source of emboli, or systemic diseases with vascular compromise. In most cases, ischaemic conditions are investigated with Doppler ultrasonography. However, computed tomography angiography (CTA) or dynamic contrast-enhanced magnetic resonance angiography (MRA) is often necessary for treatment planning. MR imaging is frequently performed with MRA to distinguish between vascular malformations, vascular tumours, and perivascular tumours. Some vascular tumours preferentially affect the hand, such as pyogenic granulomas or spindle cell haemangiomas associated with Maffucci syndrome. Glomus tumours are the most frequent perivascular tumours of the hand. The purpose of this article is to describe the state-of-the-art acquisition protocols and illustrate the different patterns of vascular lesions and perivascular tumours of the hand.

show abstract

“…Vascular anomalies have the greatest frequency in the head and neck areas and are often encountered in children (1,2). An accurate minimally invasive treatment of this condition is particularly important, considering the predominant age group, the potentially severe complications and debilitating sequelae.…”

Section: Introductionmentioning

confidence: 99%

“…According to the classification of vascular anomalies issued by the International Society for the Study of Vascular Anomalies (ISSVA), two main types of lesions make up this category -vascular tumors (including hemangiomas) and vascular malformations (comprising high-flow and lowflow lesions, as simple or combined malformations) (1,(3)(4)(5). The treatment options for vascular anomalies consist mainly of medication, sclerotherapy, embolization, laser therapy and surgical removal.…”

Section: Introductionmentioning

confidence: 99%

“…Sclerotherapy is one of the least invasive treatment methods. It consists of local intralesional injection of a sclerosing agent and it is mainly recommended for hemangiomas, as well as low-flow vascular malformations, of which venous malformations are the most common (1,7). From the multiple known sclerosing agents, bleomycin has been increasingly used in recent studies for the conservative management of head and neck vascular anomalies (8,9).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Management of head and neck hemangiomas and venous malformations by bleomycin sclerotherapy

Dragomir¹,

Ciofu²,

Doscas³

et al. 2020

Ro Med J.

View full text Add to dashboard Cite

ManageMent of head and neck heMangioMas and venous MalforMations by bleoMycin sclerotherapy lecturer raluca a. dragomir 1 , Md, phd, lecturer Mihai liviu ciofu 1 , Md, phd, assist. prof. andrada doscas 1 , Md, phd, assist. prof. alexandra carp 1 , Md, phd, lecturer bogdan dragomir 2 , Md, phd, nicolae dobrin 3 , Md, lecturer otilia boisteanu 1 , Md, phd, associate prof. victor-vlad costan 1 , Md, phd

show abstract

Vascular lesions of the head and neck: an update on classification and imaging review

Cited by 65 publications

References 73 publications

What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?

What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?

CT angiography and MRI of hand vascular lesions: technical considerations and spectrum of imaging findings

Management of head and neck hemangiomas and venous malformations by bleomycin sclerotherapy

Contact Info

Product

Resources

About